Butenafine HCl 1% Antifungal Cream delivers prescription-strength fungicidal activity targeting dermatophyte and candida species responsible for interdigital tinea pedis, tinea cruris, and tinea corporis. The benzylamine antifungal mechanism disrupts fungal cell membrane integrity, achieving rapid symptomatic resolution of pruritus, erythema, and desquamation within 7 days of consistent topical application. The greaseless cream base facilitates rapid percutaneous absorption while minimizing occlusion and maceration—critical considerations in intertriginous applications. Odorless formulation enhances patient compliance and social acceptability. Clinically validated efficacy makes this preparation suitable for acute fungal infections and prophylactic use in high-risk environments.
